![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Oxford Nanopore’s COVID-19 Test Cleared in Europe
Oxford Nanopore’s COVID-19 Test Cleared in Europe
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
October 12, 2020
Oxford Nanopore has earned a CE mark certification for its LamPORE COVID-19 test, a diagnostic that is run on the company’s desktop GridION system.
The rapid, low-cost test can be used in any laboratory and the desktop system can process up to 480 samples per run, the company said.
In a study of more than 500 samples, the test showed a sensitivity of 99.1 percent for correctly identifying positive samples and a specificity of 99.6 percent for accurately detecting negative samples.
Upcoming Events
-
21Oct